DK1558616T4 - Meso-substituerede porphyriner - Google Patents

Meso-substituerede porphyriner

Info

Publication number
DK1558616T4
DK1558616T4 DK03769429.6T DK03769429T DK1558616T4 DK 1558616 T4 DK1558616 T4 DK 1558616T4 DK 03769429 T DK03769429 T DK 03769429T DK 1558616 T4 DK1558616 T4 DK 1558616T4
Authority
DK
Denmark
Prior art keywords
meso
substituted porphyrins
porphyrins
substituted
general formula
Prior art date
Application number
DK03769429.6T
Other languages
Danish (da)
English (en)
Other versions
DK1558616T3 (da
Inventor
Gabrio Roncucci
Donata Dei
Francesca Giuntini
Giacomo Chiti
Daniele Nistri
Lia Fantetti
Valentina Paschetta
Annalisa Cocchi
Original Assignee
Molteni & C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32104761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1558616(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Molteni & C filed Critical Molteni & C
Application granted granted Critical
Publication of DK1558616T3 publication Critical patent/DK1558616T3/da
Publication of DK1558616T4 publication Critical patent/DK1558616T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03769429.6T 2002-10-21 2003-10-21 Meso-substituerede porphyriner DK1558616T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000200A ITFI20020200A1 (it) 2002-10-21 2002-10-21 Porfirine meso-sostituite.
PCT/EP2003/011642 WO2004035590A2 (en) 2002-10-21 2003-10-21 Meso-substituted porphyrins

Publications (2)

Publication Number Publication Date
DK1558616T3 DK1558616T3 (da) 2008-06-23
DK1558616T4 true DK1558616T4 (da) 2011-12-12

Family

ID=32104761

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03769429.6T DK1558616T4 (da) 2002-10-21 2003-10-21 Meso-substituerede porphyriner

Country Status (17)

Country Link
US (2) US7947674B2 (enExample)
EP (1) EP1558616B2 (enExample)
JP (1) JP4751068B2 (enExample)
CN (1) CN1714091A (enExample)
AT (1) ATE387450T1 (enExample)
AU (1) AU2003278118B8 (enExample)
CA (1) CA2503223C (enExample)
CY (1) CY1107963T1 (enExample)
DE (1) DE60319406T3 (enExample)
DK (1) DK1558616T4 (enExample)
ES (1) ES2301840T5 (enExample)
IL (1) IL168104A0 (enExample)
IT (1) ITFI20020200A1 (enExample)
PT (1) PT1558616E (enExample)
SI (1) SI1558616T2 (enExample)
WO (1) WO2004035590A2 (enExample)
ZA (1) ZA200504102B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244694T3 (es) * 2002-04-25 2005-12-16 L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI Composiciones antibacterianas que comprenden analogos de metal ftalocianina.
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
EP1631572A2 (en) * 2003-06-06 2006-03-08 Eukarion, Inc. Orally bioavailable low molecular weight metalloporphyrins as antioxidants
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB2415373A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Porphyrins for sonodynamic therapy
GB0526474D0 (en) * 2005-12-24 2006-02-08 Destiny Pharma Ltd Novel process
US7745618B2 (en) 2007-03-05 2010-06-29 North Carolina State University Method of making porphyrins
EP3459955B1 (en) * 2008-09-18 2022-11-02 biolitec Unternehmensberatungs II AG Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt
CN102180881A (zh) * 2011-03-25 2011-09-14 西北农林科技大学 3,8,13-三碘-5,10,15-三烷基三聚吲哚的制备方法
JP6182775B2 (ja) * 2011-09-21 2017-08-23 国立大学法人 岡山大学 金属ポルフィリン錯体、その製造方法及びそれからなる二酸化炭素固定化触媒、並びに、環状炭酸エステルの製造方法
CN102499924B (zh) * 2011-11-23 2013-07-24 中国医学科学院生物医学工程研究所 二乙撑三胺五乙酸或乙二胺四乙酸或胺三乙酸修饰卟啉的用途
US9364537B2 (en) 2014-08-22 2016-06-14 University Of Dayton Transition metal porphyrin complexes and methods of treatment using same
CN104725388B (zh) * 2015-03-25 2017-03-15 南京林业大学 一种meso位芳胺基单取代卟啉衍生物及其制备方法
WO2017122697A1 (ja) * 2016-01-13 2017-07-20 Jsr株式会社 感放射線性樹脂組成物、レジストパターン形成方法、酸拡散制御剤及び化合物
CN106117220A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106046010A (zh) * 2016-06-27 2016-10-26 桂林理工大学 5‑对苯甲酸基‑10, 15, 20‑三对异辛烷氧基苯基卟啉的合成方法
CN106117224A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106146522A (zh) * 2016-06-27 2016-11-23 桂林理工大学 苯并菲癸烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN105949208A (zh) * 2016-06-27 2016-09-21 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Zn配合物的合成方法
CN106047369A (zh) * 2016-06-27 2016-10-26 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106146523A (zh) * 2016-06-27 2016-11-23 桂林理工大学 苯并菲十二烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117221A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117228A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN105924448A (zh) * 2016-06-27 2016-09-07 桂林理工大学 苯并菲己烷氧基桥连十二烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117222A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料合成方法
CN106117225A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106118688A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106117223A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Ni配合物的合成方法
CN106117227A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲癸烷氧基桥连十二烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106118689A (zh) * 2016-06-27 2016-11-16 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉二元化合物盘状液晶材料的合成方法
CN106588940A (zh) * 2016-12-08 2017-04-26 桂林理工大学 苯并菲癸氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749284A (zh) * 2016-12-08 2017-05-31 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588941A (zh) * 2016-12-08 2017-04-26 桂林理工大学 苯并菲十二烷氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106588942A (zh) * 2016-12-08 2017-04-26 桂林理工大学 并菲癸氧基桥连四苯基卟啉三元化合物盘状液晶材料的合成方法
CN106749285A (zh) * 2016-12-08 2017-05-31 桂林理工大学 苯并菲己氧基桥连异辛烷氧基苯基卟啉三元化合物盘状液晶材料的合成方法
CN107089987A (zh) * 2017-04-22 2017-08-25 桂林理工大学 苯并菲己烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106967075A (zh) * 2017-04-22 2017-07-21 桂林理工大学 苯并菲癸烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN107043381A (zh) * 2017-04-22 2017-08-15 桂林理工大学 苯并菲十二烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
CN106905334A (zh) * 2017-04-22 2017-06-30 桂林理工大学 苯并菲十二烷氧基桥连甲氧羰基苯基卟啉金属Zn配合物的合成方法
CN107011349A (zh) * 2017-04-22 2017-08-04 桂林理工大学 苯并菲癸烷氧基桥连异辛烷氧基苯基卟啉金属Zn配合物的合成方法
US10722582B2 (en) * 2018-04-12 2020-07-28 Purdue Research Foundation Targeted antimicrobial photodynamic therapy
CN110354770B (zh) * 2019-07-23 2022-10-04 中国石油大学(华东) 一种人工光合微反应器及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
FR2632187B1 (fr) * 1988-06-02 1990-09-14 Centre Nat Rech Scient Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
EP0831891B1 (en) * 1995-06-07 2005-10-19 Duke University Oxidant scavengers
AU6650198A (en) * 1997-02-05 1998-08-25 Board Of Regents, The University Of Texas System Porphyrin compounds as telomerase inhibitors
IT1294325B1 (it) 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
ES2237146T3 (es) * 1998-08-28 2005-07-16 Destiny Pharma Limited Derivados de porfirina, su uso en terapia fotodinamica y dispositivos medicos que los contienen.
PT1164135E (pt) * 2000-06-15 2004-06-30 Molteni & C Frat Alitti Soc Es Metal-ftalocianinas substituidas sua preparacao e utilizacao
FR2812637B1 (fr) * 2000-08-01 2002-10-25 Anulm Ass Nantaise Pour L Util Nouveaux composes derives de dihydroporphyrine et leurs applications
DE60204767T2 (de) 2001-03-21 2006-05-18 L. Molteni & C. dei Fratelli Alitti Società di Esercizio S.p.A. Metallsubstituierte, nicht zentrosymmetrische phthalocyanin-analoga, deren herstellung und verwendung zur photodynamischen therapie, und als in-vivo-diagnostikum
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation

Also Published As

Publication number Publication date
WO2004035590A2 (en) 2004-04-29
AU2003278118B8 (en) 2009-09-17
AU2003278118A1 (en) 2004-05-04
ES2301840T5 (es) 2012-01-13
US20060040914A1 (en) 2006-02-23
US7947674B2 (en) 2011-05-24
IL168104A0 (en) 2009-02-11
CY1107963T1 (el) 2013-09-04
ES2301840T3 (es) 2008-07-01
ATE387450T1 (de) 2008-03-15
ITFI20020200A1 (it) 2004-04-22
DE60319406T2 (de) 2009-03-19
US8288528B2 (en) 2012-10-16
SI1558616T1 (sl) 2008-08-31
JP2006512301A (ja) 2006-04-13
EP1558616B1 (en) 2008-02-27
CN1714091A (zh) 2005-12-28
JP4751068B2 (ja) 2011-08-17
SI1558616T2 (sl) 2011-12-30
AU2003278118B2 (en) 2009-05-21
CA2503223C (en) 2010-11-23
DE60319406T3 (de) 2012-02-23
DK1558616T3 (da) 2008-06-23
CA2503223A1 (en) 2004-04-29
PT1558616E (pt) 2008-05-12
DE60319406D1 (de) 2008-04-10
EP1558616A2 (en) 2005-08-03
IT1333697B (enExample) 2006-05-09
ZA200504102B (en) 2006-07-26
US20110112464A1 (en) 2011-05-12
WO2004035590A3 (en) 2004-07-29
EP1558616B2 (en) 2011-08-24

Similar Documents

Publication Publication Date Title
DK1558616T3 (da) Meso-substituerede porphyriner
DE602004026113D1 (de) Glp-1-verbindungen
WO2006093891A3 (en) Photosensitizers for targeted photodynamic therapy
NO20044995L (no) Heterosykliske forbindelser
CR6577A (es) Inhibidores triciclicos de poli(adp-ribosa) polimerasas
ATE302775T1 (de) Carbolinderivate
WO2002096366A3 (en) Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
ATE484508T1 (de) Furylverbindungen
ATE524476T1 (de) Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2)
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
DE60333746D1 (de) Thienylverbindungen
GB2442915B (en) Perylenequinone derivatives and uses thereof
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
WO2003028628A3 (en) Photosensitizing carbamate derivatives
DE60315288D1 (de) Cyanoguanidin prodrugs
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
ATE248840T1 (de) Porphyrine und verwandte verbindungen
BRPI0414873A (pt) derivados de imidazopiridina como inibidores de no-sintase induzìveis
EA200702136A1 (ru) Композиции станнсопорфина и их применение
BR0308976A (pt) Terapia combinada contra tumores compreendendo derivados de acriloil distamicina substituìda e radioterapia